Global Biodefense Market Size, Status and Forecast 2022

Published On: Sep 2017

Format: PDF

Publisher: QY Research

Pages: 104

Report ID: 118586


This report studies the global Biodefense market, analyzes and researches the Biodefense development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in global market, like
Emergent Biosolutions
Hytest
GSK
Sanofi
PharmAthene
Bavarian Nordic
SIGA Technologies
Arbutus Biopharma
DynPort Vaccine
Xoma Corporation
Ichor Medical Systems
Aeolus Pharmaceuticals
Achaogen
Elusys Therapeutics
Dynavax Technologies
Cleveland BioLabs
Soligenix
Alnylam Pharmaceuticals

Market segment by Regions/Countries, this report covers
United States
EU
Japan
China
India
Southeast Asia

Market segment by Type, Biodefense can be split into
Anthrax
Smallpox
Botulism
Radiation/nuclear
Other

Market segment by Application, Biodefense can be split into
Application 1
Application 2


Table of Contents

Global Biodefense Market Size, Status and Forecast 2022
1 Industry Overview of Biodefense
1.1 Biodefense Market Overview
1.1.1 Biodefense Product Scope
1.1.2 Market Status and Outlook
1.2 Global Biodefense Market Size and Analysis by Regions
1.2.1 United States
1.2.2 EU
1.2.3 Japan
1.2.4 China
1.2.5 India
1.2.6 Southeast Asia
1.3 Biodefense Market by Type
1.3.1 Anthrax
1.3.2 Smallpox
1.3.3 Botulism
1.3.4 Radiation/nuclear
1.3.5 Other
1.4 Biodefense Market by End Users/Application
1.4.1 Application 1
1.4.2 Application 2

2 Global Biodefense Competition Analysis by Players
2.1 Biodefense Market Size (Value) by Players (2016 and 2017)
2.2 Competitive Status and Trend
2.2.1 Market Concentration Rate
2.2.2 Product/Service Differences
2.2.3 New Entrants
2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles
3.1 Emergent Biosolutions
3.1.1 Company Profile
3.1.2 Main Business/Business Overview
3.1.3 Products, Services and Solutions
3.1.4 Biodefense Revenue (Value) (2012-2017)
3.1.5 Recent Developments
3.2 Hytest
3.2.1 Company Profile
3.2.2 Main Business/Business Overview
3.2.3 Products, Services and Solutions
3.2.4 Biodefense Revenue (Value) (2012-2017)
3.2.5 Recent Developments
3.3 GSK
3.3.1 Company Profile
3.3.2 Main Business/Business Overview
3.3.3 Products, Services and Solutions
3.3.4 Biodefense Revenue (Value) (2012-2017)
3.3.5 Recent Developments
3.4 Sanofi
3.4.1 Company Profile
3.4.2 Main Business/Business Overview
3.4.3 Products, Services and Solutions
3.4.4 Biodefense Revenue (Value) (2012-2017)
3.4.5 Recent Developments
3.5 PharmAthene
3.5.1 Company Profile
3.5.2 Main Business/Business Overview
3.5.3 Products, Services and Solutions
3.5.4 Biodefense Revenue (Value) (2012-2017)
3.5.5 Recent Developments
3.6 Bavarian Nordic
3.6.1 Company Profile
3.6.2 Main Business/Business Overview
3.6.3 Products, Services and Solutions
3.6.4 Biodefense Revenue (Value) (2012-2017)
3.6.5 Recent Developments
3.7 SIGA Technologies
3.7.1 Company Profile
3.7.2 Main Business/Business Overview
3.7.3 Products, Services and Solutions
3.7.4 Biodefense Revenue (Value) (2012-2017)
3.7.5 Recent Developments
3.8 Arbutus Biopharma
3.8.1 Company Profile
3.8.2 Main Business/Business Overview
3.8.3 Products, Services and Solutions
3.8.4 Biodefense Revenue (Value) (2012-2017)
3.8.5 Recent Developments
3.9 DynPort Vaccine
3.9.1 Company Profile
3.9.2 Main Business/Business Overview
3.9.3 Products, Services and Solutions
3.9.4 Biodefense Revenue (Value) (2012-2017)
3.9.5 Recent Developments
3.10 Xoma Corporation
3.10.1 Company Profile
3.10.2 Main Business/Business Overview
3.10.3 Products, Services and Solutions
3.10.4 Biodefense Revenue (Value) (2012-2017)
3.10.5 Recent Developments
3.11 Ichor Medical Systems
3.12 Aeolus Pharmaceuticals
3.13 Achaogen
3.14 Elusys Therapeutics
3.15 Dynavax Technologies
3.16 Cleveland BioLabs
3.17 Soligenix
3.18 Alnylam Pharmaceuticals

4 Global Biodefense Market Size by Type and Application (2012-2017)
4.1 Global Biodefense Market Size by Type (2012-2017)
4.2 Global Biodefense Market Size by Application (2012-2017)
4.3 Potential Application of Biodefense in Future
4.4 Top Consumer/End Users of Biodefense

5 United States Biodefense Development Status and Outlook
5.1 United States Biodefense Market Size (2012-2017)
5.2 United States Biodefense Market Size and Market Share by Players (2016 and 2017)

6 EU Biodefense Development Status and Outlook
6.1 EU Biodefense Market Size (2012-2017)
6.2 EU Biodefense Market Size and Market Share by Players (2016 and 2017)

7 Japan Biodefense Development Status and Outlook
7.1 Japan Biodefense Market Size (2012-2017)
7.2 Japan Biodefense Market Size and Market Share by Players (2016 and 2017)

8 China Biodefense Development Status and Outlook
8.1 China Biodefense Market Size (2012-2017)
8.2 China Biodefense Market Size and Market Share by Players (2016 and 2017)

9 India Biodefense Development Status and Outlook
9.1 India Biodefense Market Size (2012-2017)
9.2 India Biodefense Market Size and Market Share by Players (2016 and 2017)

10 Southeast Asia Biodefense Development Status and Outlook
10.1 Southeast Asia Biodefense Market Size (2012-2017)
10.2 Southeast Asia Biodefense Market Size and Market Share by Players (2016 and 2017)

11 Market Forecast by Regions, Type and Application (2017-2022)
11.1 Global Biodefense Market Size (Value) by Regions (2017-2022)
11.1.1 United States Biodefense Revenue and Growth Rate (2017-2022)
11.1.2 EU Biodefense Revenue and Growth Rate (2017-2022)
11.1.3 Japan Biodefense Revenue and Growth Rate (2017-2022)
11.1.4 China Biodefense Revenue and Growth Rate (2017-2022)
11.1.5 India Biodefense Revenue and Growth Rate (2017-2022)
11.1.6 Southeast Asia Biodefense Revenue and Growth Rate (2017-2022)
11.2 Global Biodefense Market Size (Value) by Type (2017-2022)
11.3 Global Biodefense Market Size by Application (2017-2022)

12 Biodefense Market Dynamics
12.1 Biodefense Market Opportunities
12.2 Biodefense Challenge and Risk
12.2.1 Competition from Opponents
12.2.2 Downside Risks of Economy
12.3 Biodefense Market Constraints and Threat
12.3.1 Threat from Substitute
12.3.2 Government Policy
12.3.3 Technology Risks
12.4 Biodefense Market Driving Force
12.4.1 Growing Demand from Emerging Markets
12.4.2 Potential Application

13 Market Effect Factors Analysis
13.1 Technology Progress/Risk
13.1.1 Substitutes
13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs Trend/Customer Preference
13.3 External Environmental Change
13.3.1 Economic Fluctuations
13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix
Methodology
Analyst Introduction
Data Source